Mouse Anti-LANCL2 Recombinant Antibody (1C5) (CBMAB-L0684-YJ)

Tubau-Juni, N., Hontecillas, R., Leber, A. J., Alva, S. S., & Bassaganya-Riera, J. (2023). Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn’s Disease. Inflammatory Bowel Diseases, izad258.

Spinelli, S., Guida, L., Passalacqua, M., Magnone, M., Cossu, V., Sambuceti, G., ... & Zocchi, E. (2023). Abscisic Acid and Its Receptors LANCL1 and LANCL2 Control Cardiomyocyte Mitochondrial Function, Expression of Contractile, Cytoskeletal and Ion Channel Proteins and Cell Proliferation via ERRα. Antioxidants, 12(9), 1692.

Scarano, N., Di Palma, F., Origlia, N., Musumeci, F., Schenone, S., Spinelli, S., ... & Cavalli, A. (2023). New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists. Pharmaceutics, 15(12), 2754.

Maixner, D. W., Christy, D., Kong, L., Viatchenko-Karpinski, V., Horner, K. A., Hooks, S. B., & Weng, H. R. (2022). Phytohormone abscisic acid ameliorates neuropathic pain via regulating LANCL2 protein abundance and glial activation at the spinal cord. Molecular Pain, 18, 17448069221107781.

Tubau-Juni, N., Hontecillas, R., Leber, A., Maturavongsadit, P., Chauhan, J., & Bassaganya-Riera, J. (2021). First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis. Scientific Reports, 11(1), 19827.

Lou, Y., Xu, J., Zhang, Y., Zhang, W., Zhang, X., Gu, P., ... & Han, B. (2021). Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis. Cell Death & Disease, 12(2), 170.

Zhao, H. F., Zhou, X. M., Wang, J., Chen, F. F., Wu, C. P., Diao, P. Y., ... & Li, W. P. (2021). Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients. Journal of Translational Medicine, 19(1), 1-15.

Leber, A., Hontecillas, R., Tubau-Juni, N., Zoccoli-Rodriguez, V., Goodpaster, B., & Bassaganya-Riera, J. (2020). Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle. Scientific Reports, 10(1), 10463.

Leber, A., Hontecillas, R., Zoccoli-Rodriguez, V., Ehrich, M., Davis, J., Chauhan, J., & Bassaganya-Riera, J. (2019). Nonclinical toxicology and toxicokinetic profile of an oral lanthionine synthetase C-like 2 (LANCL2) agonist, BT-11. International Journal of Toxicology, 38(2), 96-109.

Leber, A., Hontecillas, R., Zoccoli-Rodriguez, V., & Bassaganya-Riera, J. (2018). Activation of LANCL2 by BT-11 ameliorates IBD by supporting regulatory T cell stability through immunometabolic mechanisms. Inflammatory Bowel Diseases, 24(9), 1978-1991.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols